CA Stock MarketDetailed Quotes

MindBio Therapeutics Corp (MBIO)

Watchlist
  • 0.770
  • -0.030-3.75%
15min DelayTrading May 22 12:51 ET
3.69MMarket Cap-0.24P/E (TTM)

MindBio Therapeutics Corp (MBIO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-216.90%-764.5K
-304.54%-42.24K
-28.86%-494.13K
-758.49%-212.67K
-142.43%-60.87K
-84.01%-241.25K
105.57%20.65K
82.66%-383.47K
95.94%-24.77K
135.81%143.45K
Net income from continuing operations
-536.92%-2.42M
-2,536.18%-1.21M
-597.48%-2.81M
-499.35%-1.44M
-1,533.45%-941.84K
-845.53%-379.34K
75.60%-45.82K
90.61%-402.47K
92.93%-240.28K
121.85%65.7K
Operating gains losses
----
----
---267.51K
----
----
----
----
----
----
----
Depreciation and amortization
----
----
----
----
--0
----
----
----
----
----
Asset impairment expenditure
----
----
--587.75K
---196.53K
----
----
----
--0
----
----
Unrealized gains and losses of investment securities
----
----
--0
----
----
----
----
-16.67%14.89K
149.39%130.54K
----
Remuneration paid in stock
--1.78M
--1.17M
--836.41K
----
----
----
----
--0
----
----
Other non cashItems
-175.50%-69.52K
99.50%-507
213.29%557.76K
55.90%357.25K
155.75%209.45K
--92.08K
---101.03K
-81.24%178.03K
-81.02%229.15K
128.40%81.9K
Change In working capital
-198.09%-57.28K
-103.40%-2.26K
444.17%598.59K
2,155.69%586.49K
-2,613.91%-112.76K
38.94%58.39K
136.27%66.48K
39.90%-173.92K
-106.35%-28.53K
-102.21%-4.16K
-Change in receivables
-457.55%-57.81K
111.66%242
314.44%3.09K
-298.71%-14.18K
244.40%29.71K
-205.03%-10.37K
-107.96%-2.08K
82.79%-1.44K
85.48%-3.56K
-1,235.37%-20.58K
-Change in prepaid assets
----
----
----
----
----
----
----
----
----
--0
-Change in payables and accrued expense
-99.23%531
-103.65%-2.5K
1,147.79%595.5K
562.44%600.67K
-967.55%-142.48K
51.37%68.76K
132.74%68.55K
85.67%-56.83K
-76.01%90.68K
-92.76%16.42K
-Change in other working capital
----
----
----
----
----
----
----
-200.00%-115.65K
----
----
Cash from discontinued investing activities
Operating cash flow
-445.21%-764.5K
47.44%-42.24K
-28.86%-494.13K
-758.49%-212.67K
-142.43%-60.87K
-6.95%-140.22K
78.34%-80.37K
82.66%-383.47K
95.94%-24.77K
135.81%143.45K
Investing cash flow
Cash flow from continuing investing activities
9.97K
0
Net business purchase and sale
----
----
--9.97K
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--9.97K
----
----
----
----
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
604.80%1.16M
0
58.38%431.14K
2,273.72%274.13K
-17
165.03K
-102.81%-8K
-73.82%272.22K
-102.24%-12.61K
0
Net issuance payments of debt
--0
--0
26.52%-9.27K
89.95%-1.27K
--0
--0
---8K
88.28%-12.61K
89.59%-12.61K
----
Net common stock issuance
----
----
--440.41K
--275.4K
---17
----
----
--0
----
----
Net other financing activities
----
----
-100.13%-360
----
----
----
----
--284.83K
--0
--0
Cash from discontinued financing activities
Financing cash flow
604.80%1.16M
--0
58.25%430.78K
2,270.87%273.77K
---17
--165.03K
-102.81%-8K
-73.82%272.22K
-102.24%-12.61K
--0
Net cash flow
Beginning cash position
-56.69%21.8K
-53.83%64.04K
69.25%-21.29K
-94.19%14.25K
-26.24%75.14K
-78.40%50.33K
-56.54%138.7K
-105.27%-69.22K
28.43%245.31K
-33.87%101.86K
Current changes in cash
1,506.95%398.6K
52.20%-42.24K
52.02%-53.38K
290.11%71.07K
-142.44%-60.88K
118.92%24.81K
-2.52%-88.37K
90.50%-111.25K
21.26%-37.38K
287.96%143.45K
Effect of exchange rate changes
----
----
-56.54%138.7K
----
----
----
----
81.72%319.18K
----
----
End cash Position
459.52%420.4K
-56.69%21.8K
-53.83%64.04K
-53.83%64.04K
-94.19%14.25K
-26.24%75.14K
-78.40%50.33K
-56.54%138.7K
-56.54%138.7K
28.43%245.31K
Free cash from
-445.21%-764.5K
47.44%-42.24K
-28.86%-494.13K
-758.49%-212.67K
-142.43%-60.87K
-6.95%-140.22K
78.34%-80.37K
82.66%-383.47K
95.94%-24.77K
135.81%143.45K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -216.90%-764.5K-304.54%-42.24K-28.86%-494.13K-758.49%-212.67K-142.43%-60.87K-84.01%-241.25K105.57%20.65K82.66%-383.47K95.94%-24.77K135.81%143.45K
Net income from continuing operations -536.92%-2.42M-2,536.18%-1.21M-597.48%-2.81M-499.35%-1.44M-1,533.45%-941.84K-845.53%-379.34K75.60%-45.82K90.61%-402.47K92.93%-240.28K121.85%65.7K
Operating gains losses -----------267.51K----------------------------
Depreciation and amortization ------------------0--------------------
Asset impairment expenditure ----------587.75K---196.53K--------------0--------
Unrealized gains and losses of investment securities ----------0-----------------16.67%14.89K149.39%130.54K----
Remuneration paid in stock --1.78M--1.17M--836.41K------------------0--------
Other non cashItems -175.50%-69.52K99.50%-507213.29%557.76K55.90%357.25K155.75%209.45K--92.08K---101.03K-81.24%178.03K-81.02%229.15K128.40%81.9K
Change In working capital -198.09%-57.28K-103.40%-2.26K444.17%598.59K2,155.69%586.49K-2,613.91%-112.76K38.94%58.39K136.27%66.48K39.90%-173.92K-106.35%-28.53K-102.21%-4.16K
-Change in receivables -457.55%-57.81K111.66%242314.44%3.09K-298.71%-14.18K244.40%29.71K-205.03%-10.37K-107.96%-2.08K82.79%-1.44K85.48%-3.56K-1,235.37%-20.58K
-Change in prepaid assets --------------------------------------0
-Change in payables and accrued expense -99.23%531-103.65%-2.5K1,147.79%595.5K562.44%600.67K-967.55%-142.48K51.37%68.76K132.74%68.55K85.67%-56.83K-76.01%90.68K-92.76%16.42K
-Change in other working capital -----------------------------200.00%-115.65K--------
Cash from discontinued investing activities
Operating cash flow -445.21%-764.5K47.44%-42.24K-28.86%-494.13K-758.49%-212.67K-142.43%-60.87K-6.95%-140.22K78.34%-80.37K82.66%-383.47K95.94%-24.77K135.81%143.45K
Investing cash flow
Cash flow from continuing investing activities 9.97K0
Net business purchase and sale ----------9.97K------------------0--------
Cash from discontinued investing activities
Investing cash flow ----------9.97K------------------0--------
Financing cash flow
Cash flow from continuing financing activities 604.80%1.16M058.38%431.14K2,273.72%274.13K-17165.03K-102.81%-8K-73.82%272.22K-102.24%-12.61K0
Net issuance payments of debt --0--026.52%-9.27K89.95%-1.27K--0--0---8K88.28%-12.61K89.59%-12.61K----
Net common stock issuance ----------440.41K--275.4K---17----------0--------
Net other financing activities ---------100.13%-360------------------284.83K--0--0
Cash from discontinued financing activities
Financing cash flow 604.80%1.16M--058.25%430.78K2,270.87%273.77K---17--165.03K-102.81%-8K-73.82%272.22K-102.24%-12.61K--0
Net cash flow
Beginning cash position -56.69%21.8K-53.83%64.04K69.25%-21.29K-94.19%14.25K-26.24%75.14K-78.40%50.33K-56.54%138.7K-105.27%-69.22K28.43%245.31K-33.87%101.86K
Current changes in cash 1,506.95%398.6K52.20%-42.24K52.02%-53.38K290.11%71.07K-142.44%-60.88K118.92%24.81K-2.52%-88.37K90.50%-111.25K21.26%-37.38K287.96%143.45K
Effect of exchange rate changes ---------56.54%138.7K----------------81.72%319.18K--------
End cash Position 459.52%420.4K-56.69%21.8K-53.83%64.04K-53.83%64.04K-94.19%14.25K-26.24%75.14K-78.40%50.33K-56.54%138.7K-56.54%138.7K28.43%245.31K
Free cash from -445.21%-764.5K47.44%-42.24K-28.86%-494.13K-758.49%-212.67K-142.43%-60.87K-6.95%-140.22K78.34%-80.37K82.66%-383.47K95.94%-24.77K135.81%143.45K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More